Angel M. Gamero-Castro
Alfenas, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Quantitative and qualitative methods for measuring chromosomal instability in tumor cells.
Journal: Cancer genetics
Published: September 22, 2025
Hydroethanolic Soy Extract Rich in Isoflavones Protects Dystrophic Mutant Mice From Oxidative Stress and Inflammation via the ROS/NF-κB Feedback Pathway.
Journal: BioFactors (Oxford, England)
Published: April 23, 2025
HDAC6 inhibition through WT161 synergizes with temozolomide, induces apoptosis, reduces cell motility, and decreases β-catenin levels in glioblastoma cells.
Journal: Investigational new drugs
Published: November 04, 2024
WT161, a selective HDAC6 inhibitor, decreases growth, enhances chemosensitivity, promotes apoptosis, and suppresses motility of melanoma cells.
Journal: Cancer chemotherapy and pharmacology
Published: September 01, 2024
Prolonged testosterone 17β-cyclopentylpropionate exposition induces behavioral, ovarian, oviductal, uterine and reproductive disturbances in female mice.
Journal: Life sciences
Published: October 27, 2023
Hydroalcoholic Myrciaria dubia (camu-camu) seed extracts prevent chromosome damage and act as antioxidant and cytotoxic agents.
Journal: Food research international (Ottawa, Ont.)
Published: March 06, 2019
G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future.
Journal: Cancer biology & medicine
Published: February 16, 2019
Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma.
Journal: Investigational new drugs
Published: December 01, 2016
Last Updated: 09/26/2026